- Home
- EOLS vs DSAC Comparison
EOLS vs DSAC Comparison
Compare EOLS & DSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EOLS | DSAC |
|---|---|---|
| Founded | 2012 | 2025 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.0M | 338.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | EOLS | DSAC |
|---|---|---|
| Price | $6.66 | $10.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 668.9K | 11.9K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $297,176,000.00 | N/A |
| Revenue This Year | $13.27 | N/A |
| Revenue Next Year | $17.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $9.90 |
| 52 Week High | $10.62 | $10.04 |
Technical Indicators
Market Signals| Indicator | EOLS | DSAC |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 72.01 |
| Support Level | $6.44 | $9.90 |
| Resistance Level | $6.77 | $10.01 |
| Average True Range (ATR) | 0.34 | 0.01 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 77.53 | 85.71 |
Price Performance
Historical ComparisonAbout EOLS Evolus Inc.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
About DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares
Daedalus Special Acquisition Corp is a blank check company.